Marshall Wace’s Intercure INCR Stock Holding History

Marshall Wace’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-112,947	Closed	-$776K	–	4061
2021 Q3	$776K	Buy	+112,947	New	+$811K	﹤0.01%	2166

Other funds holding INCR

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

RiverPark Advisors New York $219M AUM 14.91% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VIA

Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marshall Wace's INCR Position: Q4 2021 in Review

Marshall Wace sold out of Intercure (INCR) in Q4 2021, closing a stake of 112,947 shares — an estimated $776K sold.

Marshall Wace first reported a position in INCR in Q3 2021 and held it in 1 quarter. The position peaked at $776K in Q3 2021. 22 funds tracked by Wall St. Rank hold INCR as of Q4 2021.

Marshall Wace reported no remaining Intercure position as of Q4 2021 after selling out during the quarter.
Marshall Wace sold 112,947 Intercure shares in Q4 2021, an estimated $776K.
Marshall Wace first reported a position in Intercure in Q3 2021 and held it in 1 quarter.
Marshall Wace's Intercure position peaked at $776K in Q3 2021.
22 funds tracked by Wall St. Rank held Intercure as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.